Clinical & laboratory profiles and treatment outcome of Kawasaki disease in children: Experience from a tertiary care hospital
PLOS One · 2025
DOI: 10.1371/journal.pone.0328443 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Shareen Khan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculties, Department of Paediatrics & Neonatology, BIRDEM General hospital (Mother & Child wing), Segunbagicha, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Mucocutaneous Lymph Node Syndrome, Immunoglobulins, Intravenous. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
A total of 40 cases of Kawasaki Disease (KD), diagnosed & categorized on the basis of criteria set by the American Heart Association were studied. We sought to evaluate their clinical and laboratory analysis along with their treatment.
Methods
After inclusion, they underwent thorough clinical and laboratory analysis and were treated with intravenous immunoglobulin and aspirin. Their clinical & laboratory findings and treatment outcome were analyzed further using Epi info and at a probability of (p value) < 0.05, was considered statistically significant.
Results
The mean age of the cases was 4.1 ± 2.9 years and boys outnumber the girls (57% vs. 43%). Most (65%) of the cases were incomplete KD compared to 35% as complete KD. The mean duration of fever was 11.7 ± 5.53 days. The frequency of the different classic clinical findings of KD were- cracking of lips & redness of oral cavity (72%), polymorphous skin rash (50%), conjunctival injection (45%), changes in the distal extremities (38%), cervical lymphadenitis (30%) and erythema on BCG scar (7.5%). High C-Reactive protein (CRP > 10 mg/dl), thrombocytosis, anaemia and leukocytosis were 85%, 45%, 43%, 38% respectively. Echocardiography showed coronary artery abnormalities (CAA) dilatation and aneurysm in 82.5% and 12.5% cases respectively which came down to 68% and 10% after receiving treatment with IVIg and Aspirin. Conclusion & Recommendation Diagnosis of KD is essentially clinical and criteria-based and 95% were complicated with CAA. Timely intervention with IVIG was mostly effective. Therefore, high index of suspicion of a long-continued febrile child is recommended to reach the diagnosis and to initiate timely intervention so as to potentially prevent CAA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculties, Department of Paediatrics & Neonatology, BIRDEM General hospital (Mother & Child wing), Segunbagicha, Dhaka, Bangladesh.
- Pediatric Speciality Trainee, Department of Pediatrics, Nottingham University Hospital, United Kingdom.
- Retd. Ex Head of the Department, Paediatrics and Paediatric Cardiology, Armed forces medical college and Combined Military Hospital, Dhaka, Bangladesh.
- Dhaka Hospital, Nutrition Research Division, International Centre for Diarrhoeal Disease research, Bangladesh, Dhaka, Bangladesh.
ORCID-Profile: Nabila Tabassum, Mohammod Jobayer Chisti
Zitieren
APA
Khan, S., Mollah, M. A. H., Baki, A., Tabassum, N., Islam, N., Halder, A. L., Ahmed, T., Fatema, N. N., Nahar, J., Mohsin, F., & Chisti, M. J. (2025). Clinical & laboratory profiles and treatment outcome of Kawasaki disease in children: Experience from a tertiary care hospital. PLOS One. https://doi.org/10.1371/journal.pone.0328443
Vancouver
Khan S, Mollah MAH, Baki A, Tabassum N, Islam N, Halder AL, et al. Clinical & laboratory profiles and treatment outcome of Kawasaki disease in children: Experience from a tertiary care hospital. PLOS One. 2025. doi:10.1371/journal.pone.0328443
BibTeX
@article{Khan2025,
author = {Khan, Shareen and Mollah, Md Abid Hossain and Baki, Abdul and Tabassum, Nabila and Islam, Nasreen and Halder, Amrita Lal and Ahmed, Tasnima and Fatema, Nurun Nahar and Nahar, Jebun and Mohsin, Fauzia and Chisti, Mohammod Jobayer},
title = {Clinical & laboratory profiles and treatment outcome of Kawasaki disease in children: Experience from a tertiary care hospital},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0328443}
}
EUVIMED